Monogram Orthopaedics (MGRM) News Today

Monogram Orthopaedics Inc. (NASDAQ:MGRM) shares eased after Roth Capital on August 19 issued a slew of revised EPS forecasts, lifting estimates for certain quarters and fiscal years while trimming others. The mixed revisions led investors to weigh the improving longer-term outlook against near-term earnings headwinds.

Analyst actions by Roth Capital (J. Wittes):

• Positive Sentiment: Raised Q4 2026 EPS estimate to ($0.15) from ($0.32). MarketBeat Report
• Positive Sentiment: Lifted Q4 2025 EPS forecast to ($0.16) from ($0.42). MarketBeat Report
• Positive Sentiment: Boosted FY2026 EPS projection to ($0.66) from ($0.73). MarketBeat Report
• Positive Sentiment: Raised FY2025 EPS estimate to ($0.59) from ($0.81). MarketBeat Report
• Neutral Sentiment: Set FY2027 EPS at ($0.52). MarketBeat Report
• Neutral Sentiment: Forecast FY2028 EPS of ($0.11). MarketBeat Report
• Neutral Sentiment: Projected FY2029 EPS of $0.21. MarketBeat Report
• Negative Sentiment: Cut Q3 2026 EPS forecast to ($0.16) from ($0.12). MarketBeat Report
• Negative Sentiment: Lowered Q2 2026 EPS estimate to ($0.18) from ($0.14). MarketBeat Report
• Negative Sentiment: Reduced Q1 2026 EPS to ($0.17) from ($0.14). MarketBeat Report
• Negative Sentiment: Trimmed Q3 2025 EPS to ($0.18) from ($0.13). MarketBeat Report

With mixed near-term cuts offset by better long-term prospects—especially positive outyear forecasts—investors are navigating the trade-off between immediate earnings pressure and an improving outlook farther down the road.